Bacteria engineered to treat diseases that benefit from reduced gastrointestinal inflammation and / or enhanced gastrointestinal mucosal barrier

摘要

Disclosed are genetically engineered bacteria, pharmaceutical compositions thereof, and methods of treating or preventing autoimmune disorders, suppressing inflammatory mechanisms in the gastrointestinal tract, and / or enhancing gastrointestinal mucosal barrier function.